More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
AUM
$1.11B
P/E ratio
31.3
Dividend yield
1.8301%
Expense ratio
0.36%
Beta
0.433878
Previous close
$122.65
Today's open
$123.40
Day's range
$121.44 - $124.17
52 week range
$97.52 - $124.17
show more
Headquarters
US
Exchange
NASDAQ Global Market
Issue type
Exchange-Traded Fund
Industries
Health
23.26%
12.58%
NVO:CO
Novo Nordisk A/S ADR
5.42%
PFE
Pfizer, Inc.
5.07%
4.64%
4.63%
4.47%
COR
Cencora Inc
4.25%
4.23%
AZN:LN
Astrazeneca Plc, ADR
3.8%
Which Healthcare ETF Is the Better Buy: VanEck's Pharma Fund PPH or iShares' Biotech Fund IBB?
VanEck Pharmaceutical ETF offers a lower expense ratio and a higher dividend yield than iShares Biotechnology ETF. iShares Biotechnology ETF provides broader exposure with over 200 holdings, while VanEck Pharmaceutical ETF concentrates on 26 pharmaceutical leaders.
The Motley Fool • Nov 15, 2026

ETFs in Spotlight as FDA Vision Loss Warning Meets Lilly's Sleep Apnea Win
Eli Lilly's sleep apnea breakthrough amid the FDA's vision-loss warning puts diversified healthcare ETFs in the spotlight.
Zacks Investment Research • Nov 11, 2026

Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF
VanEck Pharmaceutical ETF provides a higher dividend yield and lower price volatility compared to the State Street fund. State Street SPDR Pharmaceuticals ETF offers a more diversified portfolio with more than twice as many individual holdings.
The Motley Fool • Oct 30, 2026

PPH: Key Pharmaceutical Innovations Support Bullish Outlook (Upgrade)
VanEck Pharmaceutical ETF is upgraded to Buy, driven by innovation in weight-loss treatments and robust product pipelines among top holdings. PPH's concentrated exposure to Eli Lilly, Merck, and Novo Nordisk provides key catalysts, with LLY's 49% revenue growth and novel obesity drugs leading the charge. Despite industry risks—pricing pressure, patent cliffs, and high R&D costs—PPH's top holdings are mitigating these through diversification and strong product pipelines.
Seeking Alpha • Oct 29, 2026

Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH?
Simplify Health Care ETF has a higher expense ratio and a lower dividend yield than VanEck Pharmaceutical ETF. VanEck Pharmaceutical ETF maintains a more concentrated portfolio focused exclusively on global pharmaceutical giants.
The Motley Fool • Oct 11, 2026

Execution of Pharma Tariffs Brings These ETFs Into Focus
Trump's 100% pharma tariff is reshaping the drug industry. Here's how the key pharma ETFs could be affected.
Zacks Investment Research • Oct 6, 2026

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched on December 20, 2011.
Zacks Investment Research • Oct 5, 2026

Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP
The VanEck Pharmaceutical ETF offers a lower expense ratio of 0.36% compared to 0.58% for the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF has delivered a higher 1-year total return of 41% relative to 31% for the VanEck fund.
The Motley Fool • Oct 3, 2026

Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs.
The Invesco S&P 500 Equal Weight Health Care ETF provides broader exposure with 60 holdings compared to 26 for the VanEck Pharmaceutical ETF. The VanEck Pharmaceutical ETF currently offers a significantly higher dividend yield and a lower expense ratio than its counterpart.
The Motley Fool • Sep 11, 2026

Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough
Merck-Moderna's melanoma vaccine success could boost immunotherapy growth, putting healthcare ETFs in the spotlight.
Zacks Investment Research • Sep 1, 2026

¹ Disclosures

Open an M1 investment account to buy and sell VanEck Vectors Pharmaceutical ETF commission-free¹. Build wealth for the long term using automated trading and transfers.